SGX, Roche Partner To Use FAST To Discover Antivirals Sep. 10, 2004 Entering the first major pharmaceutical deal for its Fragments of Active Structures drug discovery technology, Structural GenomiX formed an alliance with F. Hoffmann-La Roche Ltd. to discover new antiviral therapeutics. (BioWorld Today)Read More
Life Sciences Firm Serologicals To Buy Upstate For $205 Million Sep. 9, 2004 By Aaron Lorenzo Serologicals Corp. is paying $205 million to grow its business through the acquisition of Upstate Group Inc. (BioWorld Today)Read More
RSS